Eurofins CDMO Alphora Announces Major Expansion of Analytical Services

• Eurofins CDMO Alphora has significantly expanded its Drug Product Analytical Services Laboratory in Mississauga, Canada.

• The expansion includes advanced equipment and techniques for comprehensive drug product program support.

• The company reaffirms its commitment to high-quality standards and support for complex drug development programs.

Eurofins CDMO Alphora Inc., a Contract Development & Manufacturing Organization (CDMO), has recently announced a substantial expansion of its Drug Product Analytical Services Laboratory. This development has tripled the facility’s size, located in Mississauga, Canada, and marks a significant stride in the company’s capabilities.

The expansion introduces a range of specialized equipment and analytical techniques. These enhancements are designed to provide exhaustive analytical support for drug product programs, including water activity measurements, intrinsic dissolution studies, additional glove box systems, a new suite of High-Performance Liquid Chromatography (HPLC) instruments, fresh stability chambers, and gas chromatography.

“Through the Drug Product Analytical Services Laboratory expansion and our drug product capabilities, along with an extensive suite of Solid-State Research and Development, we are well-positioned to support even the most challenging drug development programs,” stated a spokesperson from Eurofins CDMO Alphora.

The company’s commitment to supporting the development and manufacturing of life-saving therapies is evident in this move. Eurofins CDMO Alphora Inc. aims to maintain the highest standards of quality, offering customized support and expert analysis to its clients.